Title : Shc inhibitor idebenone ameliorates liver injury and fibrosis in dietary NASH in mice.

Pub. Date : 2021 Oct

PMID : 34369032






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Shc inhibitor idebenone ameliorates liver injury and fibrosis in dietary NASH in mice. idebenone src homology 2 domain-containing transforming protein C1 Mus musculus
2 Idebenone was recently identified as the first small-molecule Shc inhibitor drug. idebenone src homology 2 domain-containing transforming protein C1 Mus musculus
3 In the fibrotic MCD NASH model, idebenone reduced Shc expression and phosphorylation in peripheral blood mononuclear cells and Shc expression in the liver; decreased serum alanine aminotransferase and aspartate aminotransferase; and attenuated liver fibrosis as observed by quantitative polymerase chain reaction (qPCR) and hydroxyproline quantification. idebenone src homology 2 domain-containing transforming protein C1 Mus musculus
4 In the fibrotic MCD NASH model, idebenone reduced Shc expression and phosphorylation in peripheral blood mononuclear cells and Shc expression in the liver; decreased serum alanine aminotransferase and aspartate aminotransferase; and attenuated liver fibrosis as observed by quantitative polymerase chain reaction (qPCR) and hydroxyproline quantification. idebenone src homology 2 domain-containing transforming protein C1 Mus musculus